Wang el al. reviewed nine studies comparing EGFR mutation status between primary and matched lymph node metastases in NSCLC and found that the overall discordance rate of 12.2%[7]. The gene discussed is EGFR; the disease is metastatic malignant neoplasm in the lymph nodes.